RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 116 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,990 | +56.5% | 2,020,191 | +53.3% | 0.01% | +66.7% |
Q4 2023 | $1,911 | +56.4% | 1,318,226 | +16.5% | 0.00% | +50.0% |
Q3 2023 | $1,222 | -40.1% | 1,131,826 | -28.4% | 0.00% | -33.3% |
Q2 2023 | $2,040 | -21.9% | 1,581,126 | -20.1% | 0.00% | 0.0% |
Q1 2023 | $2,612 | +118.0% | 1,978,718 | +147.8% | 0.00% | +50.0% |
Q4 2022 | $1,198 | -99.9% | 798,500 | -38.8% | 0.00% | 0.0% |
Q3 2022 | $1,540,000 | +273.8% | 1,305,226 | +258.1% | 0.00% | – |
Q2 2022 | $412,000 | -36.3% | 364,500 | +68.4% | 0.00% | -100.0% |
Q1 2022 | $647,000 | +237.0% | 216,400 | +198.1% | 0.00% | – |
Q4 2021 | $192,000 | -74.5% | 72,600 | -67.1% | 0.00% | -100.0% |
Q1 2021 | $754,000 | -89.7% | 220,500 | -89.4% | 0.00% | -87.5% |
Q4 2020 | $7,310,000 | -9.9% | 2,088,614 | -38.2% | 0.01% | 0.0% |
Q3 2020 | $8,113,000 | -23.8% | 3,380,414 | -41.9% | 0.01% | -11.1% |
Q2 2020 | $10,646,000 | +62.1% | 5,817,683 | +38.2% | 0.01% | +50.0% |
Q1 2020 | $6,566,000 | +3.1% | 4,209,123 | +41.4% | 0.01% | +20.0% |
Q4 2019 | $6,371,000 | +79.8% | 2,976,940 | +57.1% | 0.01% | +66.7% |
Q3 2019 | $3,543,000 | +939.0% | 1,894,638 | +1348.5% | 0.00% | – |
Q2 2019 | $341,000 | -78.7% | 130,800 | -79.0% | 0.00% | -100.0% |
Q1 2019 | $1,603,000 | -34.4% | 623,726 | -9.6% | 0.00% | 0.0% |
Q2 2018 | $2,442,000 | 0.0% | 689,926 | 0.0% | 0.00% | -66.7% |
Q1 2018 | $2,442,000 | -2.9% | 689,926 | +6.5% | 0.00% | 0.0% |
Q4 2017 | $2,514,000 | +326.8% | 647,826 | +179.6% | 0.00% | +200.0% |
Q3 2017 | $589,000 | -74.5% | 231,736 | -63.2% | 0.00% | -75.0% |
Q3 2016 | $2,311,000 | +30.8% | 629,800 | -20.5% | 0.00% | +33.3% |
Q2 2016 | $1,767,000 | +28.6% | 792,600 | +19.9% | 0.00% | 0.0% |
Q1 2016 | $1,374,000 | -9.2% | 660,800 | +32.3% | 0.00% | 0.0% |
Q4 2015 | $1,514,000 | +53.7% | 499,600 | +25.3% | 0.00% | +50.0% |
Q3 2015 | $985,000 | +20.9% | 398,600 | +56.9% | 0.00% | 0.0% |
Q2 2015 | $815,000 | +126.4% | 254,000 | +151.7% | 0.00% | +100.0% |
Q1 2015 | $360,000 | -69.3% | 100,900 | -80.5% | 0.00% | -66.7% |
Q4 2014 | $1,173,000 | +2.6% | 516,726 | -12.3% | 0.00% | 0.0% |
Q3 2014 | $1,143,000 | -25.2% | 589,326 | +39.9% | 0.00% | -25.0% |
Q2 2014 | $1,529,000 | +87.1% | 421,254 | +100.1% | 0.00% | +100.0% |
Q1 2014 | $817,000 | -75.1% | 210,526 | -81.7% | 0.00% | -75.0% |
Q4 2013 | $3,278,000 | +101.1% | 1,150,139 | +152.6% | 0.01% | +100.0% |
Q3 2013 | $1,630,000 | +8.2% | 455,340 | +1.0% | 0.00% | 0.0% |
Q2 2013 | $1,506,000 | – | 450,972 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |